Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Bauer

Showing results (261-270 of 281) with videos related to

Pageof 29
Sort By:
Nature Methods|September 6, 2011
Toward the blood-borne miRNome of human diseasesAndreas Keller, Petra Leidinger, Andrea Bauer, et al.
The World Allergy Organization Journal|November 18, 2020
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE studyMarcus Maurer, Karsten Weller, Markus Magerl, et al.
Clinical and Translational Allergy|December 28, 2021
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysisIvan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, et al.
The World Allergy Organization Journal|June 18, 2021
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE studyIvan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, et al.
Qatar Medical Journal|August 1, 2022
Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countriesMojca Bizjak, Mitja Košnik, Dejan Dinevski, et al.
Allergy|March 8, 2022
Adrenaline autoinjector is underprescribed in typical cold urticaria patientsMojca Bizjak, Mitja Košnik, Dejan Dinevski, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 14, 2026
Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE)Melba Muñoz, Pascale Salameh, Magdalena Zajac, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 23, 2025
Mucosal angioedema involving the oropharynx signals severe cold urticaria: COLD-CE study insightsMojca Bizjak, Daria Fomina, Jonny Peter, et al.
Allergy|December 4, 2021
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE studyMojca Bizjak, Mitja Košnik, Dejan Dinevski, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of careMarkus V Heppt, Ulrike Leiter, Theresa Steeb, et al.
Pageof 29

Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
Nature Methods|September 6, 2011
Toward the blood-borne miRNome of human diseasesAndreas Keller, Petra Leidinger, Andrea Bauer, et al.
The World Allergy Organization Journal|November 18, 2020
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE studyMarcus Maurer, Karsten Weller, Markus Magerl, et al.
Clinical and Translational Allergy|December 28, 2021
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysisIvan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, et al.
The World Allergy Organization Journal|June 18, 2021
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE studyIvan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, et al.
Qatar Medical Journal|August 1, 2022
Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countriesMojca Bizjak, Mitja Košnik, Dejan Dinevski, et al.
Allergy|March 8, 2022
Adrenaline autoinjector is underprescribed in typical cold urticaria patientsMojca Bizjak, Mitja Košnik, Dejan Dinevski, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 14, 2026
Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE)Melba Muñoz, Pascale Salameh, Magdalena Zajac, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 23, 2025
Mucosal angioedema involving the oropharynx signals severe cold urticaria: COLD-CE study insightsMojca Bizjak, Daria Fomina, Jonny Peter, et al.
Allergy|December 4, 2021
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE studyMojca Bizjak, Mitja Košnik, Dejan Dinevski, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of careMarkus V Heppt, Ulrike Leiter, Theresa Steeb, et al.
Pageof 29